Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.
Dr Emer GuinanS L DoyleA E BennettL O'NeillJ GannonJ A ElliottJ O'SullivanJ V ReynoldsJ HusseyPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2017)
Despite maintenance of body weight, functional capacity and activity habits, participants experience declines in muscle mass and strength. Interventions involving exercise and/or nutritional support to build muscle mass and strength during preoperative therapy, even in patients who are functioning normally, are warranted.
Keyphrases
- body weight
- physical activity
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- lymph node
- rectal cancer
- patients undergoing
- prognostic factors
- mental health
- skeletal muscle
- high intensity
- papillary thyroid
- peritoneal dialysis
- stem cells
- locally advanced
- squamous cell carcinoma
- radiation therapy
- patient reported outcomes
- resistance training
- bone marrow
- replacement therapy